IDT ALIGN^SM PREFERRED SEQUENCING PROVIDER PROGRAM

The Munich Leukemia Laboratory (MLL) is a leading European-based institution for leukemia diagnostics and research. The expertise embedded within the company, along with its excellent quality assurance and turnaround times, position hematological diagnostics and research teams for success.

MLL offers a wide range of genomic services, providing researchers a comprehensive picture of existing and novel illnesses within patients.

Sistemas Genómicos is the first and largest Spanish company specialized in genetic sequencing with almost two decades of experience in the field of molecular biology and genetics, specializing in techniques aimed at the fields of health, agri-food, and research.

In addition to a strong background in agricultural genomics, the company has developed advanced genetics and bioinformatics technologies for personalized biomedical research solutions. Sistemas Genómicos is a leader in Spain and internationally in research and development for genomic research services.

The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics.

MGI aims to improve the human condition by producing, studying and interpreting high-quality genome-based data that drives biological discoveries that range from the bench to the hospital bedside. MGI values the open sharing of information and ideas and encourages collaboration while also engaging the next generation of scientists through educational outreach efforts.

Predicine is a California-based molecular insights company that has developed an NGS liquid biopsy platform to analyze cfDNA and cfRNA genomic alterations in blood and urine for research. Predicine has launched its 152-gene PredicineCARE, 600-gene PredicineATLAS, and PredicineALERT MRD liquid biopsy tests for identifying cancer variants (TMB, MSI, HRD, and gene deletion), researching drug efficacy and MRD. Partnering with leading biopharmas, Predicine provides harmonized liquid biopsy tests and CDx development to support global clinical trials in the U.S., Europe, and the Asia-Pacific region, including China.

Geneseeq Technology is a research-driven company providing cutting-edge genomic sequencing to accelerate precision cancer care. Their molecular profiling informs targeted therapy and immunotherapy options in solid and blood tumors with pan-cancer panels analyzing 400+ genes and cancer-specific gene panels. The company’s high-quality genomic data and fast turnaround times also fuel translational research activities in biomarker development. In addition, they provide NGS sequencing for academic and clinical research.

Psomagen, formerly Macrogen USA, is a US-based, CLIA certified and CAP accredited genomic services company. The company delivers genetic sequencing and bioinformatics for clinical and academic research.

The company’s mission is to positively impact the health of humanity through Sanger sequencing, next generation sequencing, and microarray gene analysis services. The company is networked with Macrogen’s worldwide headquarters, which means their capabilities and expertise stretch across a diverse set of labs around the world.

Catalytic Data Science is a leading provider of discovery informatics solutions designed for both bench researchers and bioinformatics specialists.

The Catalytic platform delivers a comprehensive suite of on-demand multi-omics analysis pipelines used today by researchers at large pharmaceutical companies, early-stage biopharmaceutical companies, and academic institutions.

Catalytic’s mission is to accelerate innovation and make achieving scientific milestones more predictable through state-of-the-art informatics.